drugset / Trial / NCT00282360

Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease

NCT00282360

Phase 4 Completed 30 enrolled IRCCS San Raffaele
RandomizedParallel-groupDouble-blindTreatment

Summary

Patients with coronary artery disease have an abnormal cardiac metabolism. The hypothesis of this study is that shifting cardiac metabolism from free fatty acids to glucose will improve myocardial ischemia

Timeline

Start
1999-02
Primary completion
Completion
2003-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Trimetazidine Small molecule